Basis of HIV resistance suggests new vaccine strategy.
Senior
K
K
D016915:AIDS Vaccines / Q000494:pharmacology*; D015331:Cohort Studies; D005260:Female; D015658:HIV Infections / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control*; D018023:HIV Seronegativity; D006679:HIV Seropositivity; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular / Q000502:physiology; D015994:Incidence; D007630:Kenya / Q000453:epidemiology; D008297:Male; D012016:Reference Values; D018570:Risk Assessment; D012494:Sampling Studies; D011477:Sex Work; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D016915:AIDS Vaccines